Scholarlink

<p>Peptide-protein interactions are essential to biological processes and drug discovery, but selecting high-quality models from predicted complexes remains challenging due to high false positive rates (FPR). Here we introduce TopoDockQ, a topological deep learning model leveraging persistent combinatorial Laplacian (PCL) features to predict DockQ scores (p-DockQ) for accurately evaluating peptide-protein interface quality, aimed at enhancing precision and mitigating FPR in model selection. Compared to AlphaFold2’s built-in confidence score, TopoDockQ reduces false positives by at least 42% and increases precision by 6.7% across five evaluation datasets filtered to ≤70% peptide-protein sequence identity, while maintaining relatively high recall and F1 scores. To support flexible peptide design, we introduce ResidueX, a workflow incorporating non-canonical amino acids (ncAA) into peptide scaffolds. Together, TopoDockQ and ResidueX advance peptide-protein modeling by refining confidence scoring and supporting ncAA incorporation, enabling precise, customizable design and accelerating next-generation peptide therapeutics development.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Topological deep learning for enhancing peptide-protein complex prediction

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月12日

查看全文
  • Xuhang Dai,
  • Rui Wang,
  • Yingkai Zhang

摘要

Peptide-protein interactions are essential to biological processes and drug discovery, but selecting high-quality models from predicted complexes remains challenging due to high false positive rates (FPR). Here we introduce TopoDockQ, a topological deep learning model leveraging persistent combinatorial Laplacian (PCL) features to predict DockQ scores (p-DockQ) for accurately evaluating peptide-protein interface quality, aimed at enhancing precision and mitigating FPR in model selection. Compared to AlphaFold2’s built-in confidence score, TopoDockQ reduces false positives by at least 42% and increases precision by 6.7% across five evaluation datasets filtered to ≤70% peptide-protein sequence identity, while maintaining relatively high recall and F1 scores. To support flexible peptide design, we introduce ResidueX, a workflow incorporating non-canonical amino acids (ncAA) into peptide scaffolds. Together, TopoDockQ and ResidueX advance peptide-protein modeling by refining confidence scoring and supporting ncAA incorporation, enabling precise, customizable design and accelerating next-generation peptide therapeutics development.